Skip navigation

Food Standards Agency

Monday 22 March 2010

Business campaign

AZ-Directory What's New

T07033: The immunomodulatory role of maternal IgG in infant atopic programming

Tuesday 2 March 2004

This project aims to investigate if differences in maternal IgG during pregnancy direct the form of allergen encountered in utero and later infant atopic phenotype.

Study Duration : May 2003 to March 2005

Contractor : University of Southampton

Background

IgE sensitisation is commonly associated with food reactions and other allergic symptoms in childhood. While the mechanism of sensitisation is unknown, much evidence suggests that the allergic cascade may be triggered in early life. This is thought to indicate a key regulatory role for maternally derived factors.

Research Approach

From an infant cohort at genetic risk of atopy, serum egg ovalbumin (OVA) IgG and subclass concentrations and avidity will be measured at birth and correlated with allergic outcome. OVA antigen formed at birth will also be analysed in relation to IgG and later atopic phenotype. Furthermore, the mechanism by which IgG might regulate immune responses will be examined by assessing T-cell and B-cell OVA epitope recognition in relation to IgG characteristics.

Tell a Friend

Printer friendly

Contact us

Get alerts

Our Sites

Find out what our other sites have to offer

Change Text Only Settings

Graphic version of this page